Your cart is currently empty!
“ISO 17097:2024 3-D human body scan data – Methods for the processing of human body scan data” has been added to your cart. View cart
ISO 18362:2016
ISO 18362:2016 Manufacture of cell-based health care products – Control of microbial risks during processing
CDN $273.00
Description
ISO 18362:2016 specifies the minimum requirements for, and provides guidance on, a risk-based approach for the processing of cell-based health care products (CBHPs) requiring control of viable and non-viable microbial contamination. It is applicable both to CBHPs labelled ‘sterile’ and to CBHPs not labelled ‘sterile’.
ISO 18362:2016 is not applicable to:
– procurement and transport of cell-based starting material used in processing of a CBHP,
– cell banking,
– control of genetic material,
– control of non-microbial product contamination,
– in vitro diagnostics (IVDs), or
– natural medicines.
EXAMPLE Vitamins and minerals, herbal remedies, homoeopathic medicines, traditional medicines such as traditional Chinese medicines, probiotics, other products such as amino acids and essential fatty acids.
ISO 18362:2016 does not define biosafety containment requirements.
ISO 18362:2016 does not replace national or regional regulations that apply to the manufacture and quality control of a CBHP.
Edition
1
Published Date
2016-01-15
Status
PUBLISHED
Pages
32
Language
English
Format
Secure PDF
Secure – PDF details
- Save your file locally or view it via a web viewer
- Viewing permissions are restricted exclusively to the purchaser
- Device limits - 3
- Printing – Enabled only to print (1) copy
See more about our Environmental Commitment
Abstract
ISO 18362:2016 specifies the minimum requirements for, and provides guidance on, a risk-based approach for the processing of cell-based health care products (CBHPs) requiring control of viable and non-viable microbial contamination. It is applicable both to CBHPs labelled 'sterile' and to CBHPs not labelled 'sterile'.
ISO 18362:2016 is not applicable to:
- procurement and transport of cell-based starting material used in processing of a CBHP,
- cell banking,
- control of genetic material,
- control of non-microbial product contamination,
- in vitro diagnostics (IVDs), or
- natural medicines.
EXAMPLE Vitamins and minerals, herbal remedies, homoeopathic medicines, traditional medicines such as traditional Chinese medicines, probiotics, other products such as amino acids and essential fatty acids.
ISO 18362:2016 does not define biosafety containment requirements.
ISO 18362:2016 does not replace national or regional regulations that apply to the manufacture and quality control of a CBHP.
Previous Editions
Can’t find what you are looking for?
Please contact us at:
Related Documents
-
ISO 16840:2023 Wheelchair seating – Part 14: Concepts related to managing external forces to maintain tissue integrity
CDN $115.00 Add to cart -
ISO 17097:2024 3-D human body scan data – Methods for the processing of human body scan data
CDN $173.00 Add to cart -
ISO 1991:1982 Vegetables – Nomenclature – First list
CDN $115.00 Add to cart -
ISO 20537:2025 Footwear – Identification of defects during visual inspection – Vocabulary
CDN $273.00 Add to cart
